LB54640

· Rhythm Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LB54640, covering 2023-11-02 to 2026-02-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity [Phase 2]